CDSCO (India)
NOTICE
Strict compliance with the Drugs Rules, 1945, for testing of raw materials and finished formulations
Published: 10/27/2026Detected: 10/28/2026
Summary preview
Reinforces the expectation that India-regulated drug manufacturers strictly comply with the Drugs Rules, 1945 when conducting testing for both raw materials and finished formulations.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
safety
labeling
#India CDSCO
#Drugs Rules 1945
#raw material testing
#finished formulation testing
#quality control
Official Source Document Source Verified
Access the original document directly from INDIA CDSCO.
More from CDSCO (India)
- Misleading or false claims of the product FatX solution registered under COS-2 vide RC no. RC/COS-003300 by the firm M/s Tekno Midas Aesthetics10/26/2026
- WHO Alert on falsified DEFITELIO (Defibrotide) 80 mg/ml concentrate for solution for infusion, B. No. 24GC01A, Exp date 04/2027, Mfg by: Patheon, II Trav. sx Via Morolense, 5, 03013 Ferentino (FR) Italy and Marketing authorisation holder: Gentium S.r.l, Piazza XX Settembre, 2, 22079 Villa Guardia (Como) Italy and identified in India10/26/2026
- List of Ethics Committees cancelled by CLA10/19/2026
- Clarification regarding requirement of Export NOC for already approved r-DNA products.10/14/2026
- 2026.10.13 S.O. 5617(E), Notification of Government Analysts for veterinary vaccines at CCSNIAH, Baghpat10/13/2026